AI Article Synopsis

  • - Sortase A (SrtA) is typically used for attaching labels to proteins but has limitations due to its reversibility and the need for a specific amino acid sequence (LPxTG).
  • - Researchers discovered that SrtA can irreversibly link proteins/peptides with a thioester at one end to those with a Gly at the other end, allowing for flexibility beyond the traditional LPxTG requirement.
  • - This new approach allows for the easy creation of proteins with various labels, including modified proteins like phosphorylated and methylated histones, demonstrating that substrate modification can improve existing enzymatic techniques.

Article Abstract

Sortase A (SrtA)-mediated ligation, a popular method for protein labeling and semi-synthesis, is limited by its reversibility and dependence on the LPxTG motif, where "x" is any amino acid. Here, we report that SrtA can mediate the efficient and irreversible ligation of a protein/peptide containing a C-terminal thioester with another protein/peptide bearing an N-terminal Gly, with broad tolerance for a wide variety of LPxT-derived sequences. This strategy, the thioester-assisted SrtA-mediated ligation, enabled the expedient preparation of proteins bearing various N- or C-terminal labels, including post-translationally modified proteins such as the Ser139-phosphorylated histone H2AX and Lys9-methylated histone H3, with less dependence on the LPxTG motif. Our study validates the chemical modification of substrates as an effective means of augmenting the synthetic capability of existing enzymatic methods.

Download full-text PDF

Source
http://dx.doi.org/10.1002/anie.202201887DOI Listing

Publication Analysis

Top Keywords

srta-mediated ligation
8
dependence lpxtg
8
lpxtg motif
8
thioester-assisted sortase-a-mediated
4
ligation
4
sortase-a-mediated ligation
4
ligation sortase
4
sortase srta-mediated
4
ligation popular
4
popular method
4

Similar Publications

Cancer vaccines are a promising strategy to increase tumor-specific immune responses in patients who do not adequately respond to checkpoint inhibitors. Cancer vaccines that contain patient-specific tumor antigens are most effective but also necessitate the production of patient-specific vaccines. This study aims to develop a versatile cancer vaccine format in which patient-specific tumor antigens can be site-specifically conjugated by a proximity-based Sortase A (SrtA)-mediated ligation (PBSL) approach to antibodies that specifically bind to antigen-presenting cells to stimulate immune responses.

View Article and Find Full Text PDF

Chemo-Enzymatic Functionalization of Bovine Milk Exosomes with an EGFR Nanobody for Target-specific Drug Delivery.

Chembiochem

November 2024

Key Laboratory of Carbohydrate Chemistry & Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, No. 1800, Lihu Avenue, Wuxi, 214122, China.

Bovine milk exosomes (BmExo) have been identified as versatile nanovesicles for anti-cancer drugs delivery due to their natural availability and biocompatibility. However, tumor-specific delivery based on BmExo often requires post-isolation modifications of the membrane surface with active-targeting ligands. In this study, we report an alternative approach to functionalize BmExo with nanobody combining facile chemical modification and Sortase A-mediated site-specific ligation, as demonstrated by the development of an epidermal growth factor receptor (EGFR)-targeted drug delivery system.

View Article and Find Full Text PDF

A dual biomarker-targeting probe enables signal-on surface labeling of Staphylococcus aureus.

Bioorg Med Chem Lett

September 2023

Department of Chemical Biology, College of Chemistry and Chemical Engineering, the Key Laboratory for Chemical Biology of Fujian Province, State Key Laboratory for Physical Chemistry of Solid Surfaces, Xiamen University, Xiamen 361005, China. Electronic address:

Imaging or killing of a specific pathogen is of significance for precise therapy. Staphylococcus aureus (S. aureus) is an infectious gram-positive bacteria relying on Sortase A (SrtA) to anchor cell surface protein on peptidoglycan.

View Article and Find Full Text PDF

Antagonistic Insulin Derivative Suppresses Insulin-Induced Hypoglycemia.

J Med Chem

June 2023

Division of Endocrinology and Diabetes, Department of Pediatrics, School of Medicine, Stanford University, Palo Alto, California 94305, United States.

Insulin derivatives provide new functions that are distinctive from native insulin. We investigated insulin modifications on the C-terminal A chain with insulin receptor (IR) peptide binders and presented a full and potent IR antagonist. We prepared insulin precursors featuring a sortase A (SrtA) recognition sequence, LPETGG, at the C-terminal A chain and used a SrtA-mediated ligation method to synthesize insulin derivatives.

View Article and Find Full Text PDF
Article Synopsis
  • - Sortase A (SrtA) is typically used for attaching labels to proteins but has limitations due to its reversibility and the need for a specific amino acid sequence (LPxTG).
  • - Researchers discovered that SrtA can irreversibly link proteins/peptides with a thioester at one end to those with a Gly at the other end, allowing for flexibility beyond the traditional LPxTG requirement.
  • - This new approach allows for the easy creation of proteins with various labels, including modified proteins like phosphorylated and methylated histones, demonstrating that substrate modification can improve existing enzymatic techniques.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!